ENRUHE
PF-Atlas › Clinical Trials › NCT07809867

Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis

Elexacaftor, Tezacaftor, Ivacaftor · Phase 4

Registry ID
NCT07809867
Phase
Phase 4
Status
Recruiting
Drug / intervention
Elexacaftor, Tezacaftor, Ivacaftor
Sponsor
Istituto Giannina Gaslini
Start
2026-09-18

About this trial

Elexacaftor, Tezacaftor, Ivacaftor is evaluated in NCT07809867, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Istituto Giannina Gaslini. Current status: Recruiting.

View NCT07809867 on ClinicalTrials.gov →

Explore related

All Elexacaftor, Tezacaftor, Ivacaftor trialsAll IPF trials

Related trials

Elexacaftor, Tezacaftor, Ivacaftor — NCT07363304
Medical disclaimer. This page summarizes public trial data for NCT07809867 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.